Physician profile
Mary Murray
NPI 1861553695
$3,139.98
in general payments reported to CMS, 2019-2025
21 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $42.35 · 2021: $787 · 2022: $1,250 · 2023: $438 · 2024: $289 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.70 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $1,494.78 | 2021-2022 | |
| Exeltis, USA INC. | $429.92 | 2019-2024 | Slynd |
| Abbvie INC. | $220.21 | 2021-2024 | |
| Allergan, INC. | $163.41 | 2019-2020 | |
| Hologic Sales and Service, LLC | $115.38 | 2021-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Fluent Fluid Management System, Acessa Provu System |
| Mayne Pharma Commercial LLC | $101.34 | 2022-2025 | |
| Exact Sciences Corporation | $76.76 | 2023-2024 | Cologuard Collection Kit |
| Urovant Sciences INC | $73.44 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.58 | 2019-2023 | |
| Cytyc Surgical Products, LLC | $67.07 | 2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Novasure |
| Therapeuticsmd, INC. | $49.53 | 2019-2022 | |
| Agile Therapeutics, INC. | $45.70 | 2022 | |
| Millicent US INC | $45.00 | 2025 | |
| Sumitomo Pharma America, INC. | $41.31 | 2023 | Gemtesa |
| Merck Sharp & Dohme LLC | $37.62 | 2023-2024 | Gardasil 9, Gardasil |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $24.07 | 2019-2021 | |
| Shield Therapeutics INC | $23.62 | 2024 | |
| Convatec INC. | $19.46 | 2024 | |
| Daiichi Sankyo INC. | $16.67 | 2022 | |
| Evofem Biosciences, INC. | $12.85 | 2022 | |
| Channel Medsystems, INC. | $10.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.